Key points are not available for this paper at this time.
This cross-sectional study evaluates aspects of xylazine adulteration of opioids among individuals entering substance use disorder treatment.
Share your take
Add a clinician perspective alongside expert commentary.
Hochheimer et al. (Wed,) studied this question.